Effect of Almond Milk Versus Cow Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Overweight or Obesity and Type 2 Diabetes: A Randomized Controlled Clinical Trial
Nutrients · 2025
DOI: 10.3390/nu17132092 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Shilton Dhaver und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical, Behavioral & Outcomes Research, Joslin Diabetes Center, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 2, Gastrointestinal Hormones, Lipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Dairy Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Almond milk is often seen as a healthier alternative to cow milk. However, its effect on postprandial glycemia compared to 2% milk is unclear. Here, we compared the postprandial glycemic effect of almond milk versus carbohydrate- or caloric-matched 2% milk, each served with oatmeal to patients with type 2 diabetes (T2D).
Methods
In this crossover, three-way, open-label study, 22 participants (mean age 66 ± 7.4 years, 36% female), with T2D and overweight or obesity, consumed oatmeal served with almond milk (ALM), carbohydrate-matched 2% milk (MLKCRB), or calorie-matched 2% milk (MLKCAL) on separate days and in a random order. The primary outcome was glucose incremental area under the curve for 240 min (iAUC0-240). The secondary outcomes included postprandial serum insulin, glucagon, plasma free fatty acids (FFAs), serum triglycerides, leptin, and gastrointestinal hormones (PYY, active GLP-1, GIP, amylin, cholecystokinin, and ghrelin).
Results
We did not find any difference in either the primary endpoint or secondary endpoints between the three groups. However, iAUC0-240 for insulin and glucagon was significantly higher in MLKCRB vs. ALM (FDR = 0.002 and 0.02, respectively).
Conclusions
Almond milk does not offer any additional glycemic benefit over 2% milk and does not differ in its postprandial effects on FFAs, serum triglycerides, leptin, and gastrointestinal hormones over 4 h. Nonetheless, carbohydrate-matched 2% milk elicited greater insulin and glucagon response compared to almond milk, warranting further investigation into its long-term implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical, Behavioral & Outcomes Research, Joslin Diabetes Center, Boston, MA 02215, USA.
- Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Shilton Dhaver, Marwa Al-Badri, Abd Almasih Barbar Askar
Förderung
- NIDDK NIH HHS
- National Dairy Council
Zitieren
APA
Dhaver, S., Al-Badri, M., Mitri, J., Barbar Askar, A. A., Mottalib, A., & Hamdy, O. (2025). Effect of Almond Milk Versus Cow Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Overweight or Obesity and Type 2 Diabetes: A Randomized Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu17132092
Vancouver
Dhaver S, Al-Badri M, Mitri J, Barbar Askar AA, Mottalib A, Hamdy O. Effect of Almond Milk Versus Cow Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Overweight or Obesity and Type 2 Diabetes: A Randomized Controlled Clinical Trial. Nutrients. 2025. doi:10.3390/nu17132092
BibTeX
@article{Dhaver2025,
author = {Dhaver, Shilton and Al-Badri, Marwa and Mitri, Joanna and Barbar Askar, Abd Almasih and Mottalib, Adham and Hamdy, Osama},
title = {Effect of Almond Milk Versus Cow Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Overweight or Obesity and Type 2 Diabetes: A Randomized Controlled Clinical Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17132092}
}
EUVIMED